Keller Graduate School of management
Equities have greeted 2018 with a bang, but none more so than Korean pharmaceutical maker Celltrion Inc., which has piled on about 9 trillion won ($8.4 billion) of market value in just seven days.
Pharm Exec's latest annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
On Thursday the major markets closed in green zone again. DJIA +0.73%, Nasdaq +0.57%, S&P500 +0.53%! Biotech market also has raised: NASDAQ Biotechnology (NBI) +0.33%! Shares of Prothena Corporation plc (PRTA) +5.02% and Foamix Pharmaceuticals Ltd (FOMX) +7.12% had raised. Shares of Immune Desi (IMDZ) -6.53% and XBiotech Inc. (XBIT) -15.49% had fallen! Sage Therapeutic (SAGE) stocks increased $0.45 and closed at $6.77 (+7.12%). The trading volume exceeded 5 times the average trading: 534K vs. 164K. The company's capitalization was $208M. The minimum FOMX share price: $5.48, while the maximum price: $12.20.
The first day of the week demonstrated various market indexes: DJIA -0.10%, NASDAQ: + 0.14%, S & P500 -0.04%. Biotech showed a slight increase: NASDAQ Biotechnology (^ NBI) + 0.49%.
Friday was very positive for main indices: SP500 gained 1.10%, Dow Jones Industrial went 0.90% up and NASDAQ showed impressive 2.27% gain. Biotech market was on the raise as well: NASDAQ Biotechnology (^NBI) gained 2.86%!
Today biotech sector gained a bit: NASDAQ Biotechnology (^NBI) closed at 0.57% higher than yesterday (+18.14). Not much comparing to gaines by Dow Jones +1.87% (+320.55!), Nasdaq +1.65% (+79.93) and S&P500 +1.66% (+33.57).